Heidi M Haikala
11PUBLICATIONS
86CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (11)
Sort by Publication Date:
|Feb 04, 2026
Functionally Characterizing the Renal Cell Carcinoma Tumor-Immune Microenvironment via Patient-Derived Ex Vivo Models.Neja Sirc, Johannes Smolander, Anita N Kumari
|Jan 02, 2025
Intratumor heterogeneity of EGFR expression mediates targeted therapy resistance and formation of drug tolerant microenvironment.Bassel Alsaed, Linh Lin, Jieun Son
|Oct 09, 2023
Inhibition of CDK12 elevates cancer cell dependence on P-TEFb by stimulation of RNA polymerase II pause release.Zhijia Wang, Samu V Himanen, Heidi M Haikala
|Feb 12, 2022
A Novel HER2-Selective Kinase Inhibitor Is Effective in HER2 Mutant and Amplified Non-Small Cell Lung Cancer.Jieun Son, Jaebong Jang, Tyler S Beyett
|Jan 29, 2022
Comparative Analysis and Isoform-Specific Therapeutic Vulnerabilities of KRAS Mutations in Non-Small Cell Lung Cancer.Biagio Ricciuti, Jieun Son, Jeffrey J Okoro
|Sep 22, 2021
EGFR Inhibition Enhances the Cellular Uptake and Antitumor-Activity of the HER3 Antibody-Drug Conjugate HER3-DXd.Heidi M Haikala, Timothy Lopez, Jens Köhler
Pageof 2
Frequent Collaborators
5 joint publications
Pasi A Jänne
4 joint publications
Satu Mustjoki
3 joint publications
Tero Aittokallio
3 joint publications
Jieun Son
3 joint publications
Pınar Özden Eser
2 joint publications
Diego Balboa
2 joint publications
Bjoern Von Eyss
2 joint publications
Timo Otonkoski
2 joint publications
Harri Sihto
2 joint publications
Martin Eilers
